Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Collection of Blood for Multiple Collaborative Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01336855
Recruitment Status : Recruiting
First Posted : April 18, 2011
Last Update Posted : May 19, 2022
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Condition or disease

Detailed Description:
HIV positive patients are currently the focus of multiple collaborative research studies, both at UCSF and other institutions. The aims of these research projects include improving the understanding of etiology, immunology, epidemiology and treatment of HIV. There are numerous requests from basic scientists at UCSF for collaborative studies on specimens, especially for blood, saliva and urine samples. Specimens may be used to test such things as virus characteristics, genotyping and/or phenotyping resistance, plasma drug concentrations, immune function or evidence of complications of HIV disease. The samples may also be tested for genetic factors that may be related to the course of HIV disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Collection and Preservation of Blood and Serum Specimens From HIV Positive or HIV Negative Patients for Multiple Collaborative Studies
Study Start Date : January 1988
Estimated Primary Completion Date : January 2025
Estimated Study Completion Date : January 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

HIV Positive
HIV-1 positive subjects
HIV negative subjects
HIV-1 seronegative control group

Primary Outcome Measures :
  1. Plasma HIV RNA level [ Time Frame: Ongoing ]
    Viral load

Biospecimen Retention:   Samples With DNA
Plasma, PBMCs, buffy coat, serum, saliva, urine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Subjects will be selected based on positive or negative HIV antibody, depending on the study for which blood is being collected. Patients will be chosen from the Positive Health Practice populations at SFGH and UCSF, the General Medicine Clinic at the San Francisco Veterans Affairs Medical Center. HIV uninfected healthy volunteers with comparable risk factors to the HIV positive subjects will be recruited from the community.

Inclusion Criteria:

  • HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
  • HIV-positive subjects naive to antiretroviral therapy
  • HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months
  • Good venous access
  • Able to provide informed consent

Exclusion Criteria:

  • Hemoglobin < 9g/dl
  • Hematocrit < 27%
  • Active treatment for cancer
  • Hospitalization or IV antibiotic use within the last 4 months
  • Immunosuppressive therapy within the last 4 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01336855

Layout table for location contacts
Contact: Rebecca Hoh, M.S., R.D. 415-476-4082 ext 139
Contact: Viva Tai, MS. RD 415-476-4082 ext 104

Layout table for location information
United States, California
San Francisco General Hospital Recruiting
San Francisco, California, United States, 94110
Sponsors and Collaborators
University of California, San Francisco
Layout table for investigator information
Principal Investigator: Steven Deeks, M.D. University of Californa, San Francisco
Layout table for additonal information
Responsible Party: University of California, San Francisco Identifier: NCT01336855    
Other Study ID Numbers: H8211-04743-22
First Posted: April 18, 2011    Key Record Dates
Last Update Posted: May 19, 2022
Last Verified: May 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of California, San Francisco:
Healthy control
Men who have sex with men